 |
Myriad Genetics MYGN (news,
chart,
quote) - MYGN volatility up into Alzheimer's data
MYGN is recently trading at $48.71. MYGN's Flurizan, a treatment for Alzheimer's diseases is expected release top-line results in June. MYGN June option implied volatility of 105 is above its 6-month average of 63 according to Track Data, suggesting larger price uncertainty.
|
|
|
|
